Site-Resolved Plasma-Protein Architecture of Infection Susceptibility: A Cis-pQTL Mendelian Randomization and Colocalization Study. [PDF]
Ji S, Li T.
europepmc +1 more source
Pharmacogenomics of Antineoplastic Therapy in Children: Genetic Determinants of Toxicity and Efficacy. [PDF]
Dushimova Z +6 more
europepmc +1 more source
From Conventional Therapy to Precision Medicine in Inflammatory Bowel Disease: A State-of-the-Art Review. [PDF]
Almajdi A, Shehab M.
europepmc +1 more source
Pharmacogenomics and Epigenetic Regulation Transforming Pediatric Precision Therapeutics. [PDF]
Satyam SM +9 more
europepmc +1 more source
Pharmacogenomic impact and genetic architecture of toxicity in pediatric acute lymphoblastic leukemia induction therapy: an exploratory modeling approach. [PDF]
Gutierrez-Cáceres C +10 more
europepmc +1 more source
Utjecaj varijanti gena TPMT i NUDT15 na terapiju tiopurinima
Metabolizam tiopurina uključuje enzime TPMT i NUDT15, čija smanjena ili odsutna aktivnost dovodi do prekomjernog nakupljanja aktivnih tiogvaninskih nukleotida te posljedično povećava rizik od nuspojava izazvanih tiopurinima. Genotipizacija TPMT i NUDT15 važna je za utvrđivanje varijanti gena povezanih s promijenjenom enzimskom aktivnošću.
openaire +1 more source
The multifaceted regulatory roles of Nudix hydrolases in cancer and their therapeutic potential. [PDF]
Pan J, Yang J, Wang K.
europepmc +1 more source
A Strategic Implementation Framework for Integrating Pharmacogenomics (PGx) into Personalized Healthcare in Saudi Arabia. [PDF]
Alrubaie KR +6 more
europepmc +1 more source
Therapeutic Drug Monitoring and Pharmacogenomics of Thiopurines in Inflammatory Bowel Disease: International Guidelines Revisited. [PDF]
Bayoumy AB, Derijks LJJ, de Boer NKH.
europepmc +1 more source
Unraveling Novel Genetic Determinants of Thiopurine Response Via TWAS. [PDF]
Bidoli C +5 more
europepmc +1 more source

